161771-76-2

Basic information

• Product Name: 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-
• Synonyms: 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-;PidotiMod Diketopiperazine Dihydro-1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine-5,8,10(5ah,10ah)-trione;PidotiMod IMp.Y;Pidotimod Impurity Z;Pidotimod Impurity 4;Dihydro-1H,5H-pyrrolo[1,2-a][1,3]thiazolo[3,4-d]pyrazine-5,8,10(5aH,10aH)-trione;dihydro-1H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine-5,8,10(3H,5aH,10aH)-trione
• CAS NO: 161771-76-2
• Molecular Formula: C9H10N2O3S
• Molecular Weight: 226.2523
• Mol File: 161771-76-2.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-(161771-76-2)
• EPA Substance Registry System: 1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro-(161771-76-2)

Safety Data

• Hazardous Substances Data: 161771-76-2(Hazardous Substances Data)

Usage

Description

Pidotimod Impurity Y is a chemical compound that is an impurity of the immunomodulatory drug Pidotimod. It is a byproduct produced during the manufacturing process of Pidotimod and must be monitored and controlled to ensure the quality and safety of the drug.

Uses

Since Pidotimod Impurity Y is an impurity, it does not have specific applications like the main drug Pidotimod. However, its control and removal are essential in the pharmaceutical industry for the following reasons:
1. Ensuring the Efficacy of Pidotimod: Pidotimod Impurity Y may affect the efficacy of the main drug, so its removal helps maintain the desired therapeutic effects of Pidotimod.
2. Ensuring the Safety of Pidotimod: The presence of Pidotimod Impurity Y may pose a risk to the safety of the drug. By controlling and removing this impurity, the pharmaceutical industry can ensure the safety of Pidotimod products for patients.
3. Compliance with Regulatory Standards: Chemical analysis and purification methods are used to detect and remove Pidotimod Impurity Y from Pidotimod products, in accordance with regulatory standards. This ensures that the final drug product meets the required quality and safety criteria.